Literature DB >> 3106491

Interferon blocks interleukin 1-induced prostaglandin release from human peripheral monocytes.

J L Browning, A Ribolini.   

Abstract

We have studied the short-term effects of interleukin 1, lipopolysaccharide, and interferon on prostaglandin release from freshly isolated human peripheral monocytes. When the cells were pretreated for 8 to 9 hr with either E. coli lipopolysaccharide or recombinant interleukin 1 (beta), prostaglandin release increased. Inclusion of recombinant IFN-alpha or IFN-gamma during the pretreatment phase blocked subsequent prostaglandin release. Interferons were effective at concentrations in the range of 1 to 10 antiviral units/ml, and the inhibition was manifested within several hours after exposure to the lymphokine. Similar trends were observed by measuring thromboxane release. These data suggest antagonistic roles for interleukin 1 and interferon in the regulation of eicosanoid release from monocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106491

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  21 in total

1.  IL-18 binding protein increases spontaneous and IL-1-induced prostaglandin production via inhibition of IFN-gamma.

Authors:  L L Reznikov; S H Kim; J Y Westcott; J Frishman; G Fantuzzi; D Novick; M Rubinstein; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

2.  Heterogeneity of interleukin 1 production in cultured Reed-Sternberg cell lines HDLM-1, HDLM-1d, and KM-H2.

Authors:  S M Hsu; K Krupen; L B Lachman
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

3.  Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-gamma prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin 1.

Authors:  N E Reiner; W Ng; C B Wilson; W R McMaster; S K Burchett
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

4.  Effect of in vivo administration of recombinant murine gamma interferon on in vitro lymphoproliferative responses following immunization with Candida albicans.

Authors:  R E Garner; U Kuruganti; L A al-Hussaini; C W Czarniecki; J E Domer
Journal:  Infect Immun       Date:  1992-05       Impact factor: 3.441

Review 5.  Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases.

Authors:  D S Hallegua; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

Review 6.  Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases.

Authors:  Xiaoyu Hu; Lionel B Ivashkiv
Journal:  Immunity       Date:  2009-10-16       Impact factor: 31.745

7.  Characterization of phospholipase A2 in monocytic cell lines. Functional and biochemical aspects of membrane association.

Authors:  W Rehfeldt; R Hass; M Goppelt-Struebe
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

8.  Interleukin-18 gene polymorphism, but not interleukin-2 gene polymorphism, is associated with rheumatoid arthritis.

Authors:  Cheng-Chun Lee; Wei-Yong Lin; Lei Wan; Yuhsin Tsai; Ying-Ju Lin; Chang-Hai Tsai; Chung-Ming Huang; Fuu-Jen Tsai
Journal:  Immunogenetics       Date:  2007-03-30       Impact factor: 2.846

9.  Comparison of retroviral p15E-related factors and interferon alpha in head and neck cancer.

Authors:  P J Simons; R A Oostendorp; M P Tas; H A Drexhage
Journal:  Cancer Immunol Immunother       Date:  1994-03       Impact factor: 6.968

10.  Expression of prostaglandin H synthase (cyclooxygenase) in Hodgkin's mononuclear and Reed-Sternberg cells. Functional resemblance between H-RS cells and histiocytes or interdigitating reticulum cells.

Authors:  S M Hsu; P L Hsu; S S Lo; K K Wu
Journal:  Am J Pathol       Date:  1988-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.